Concepedia

Judith A. Veitch

JA

Statistics

Publications

5

Citations

157

H-Index

5

Active since

1989

Affiliations

Bristol-Myers Squibb (United States)(Current)

Judith A. Veitch is an author at Bristol-Myers Squibb (United States) specializing in drug discovery, life sciences, and antitumor antibiotic biosynthesis.

Publications per year

1989–1997

5

Publications

5

Biosynthesis of esperamicin A1, an enediyne antitumor antibiotic

Kin S. Lam, Judith A. Veitch, Jerzy Golik et al. · Journal of the American Chemical Society · 1993 · 57 citations

, , +7

BMS-182123, a Fungal Metabolite that Inhibits the Production of TNF-.ALPHA. by Macrophages and Monocytes.

Glenn A. Warr, Judith A. Veitch, Ann W. Walsh et al. · The Journal of Antibiotics · 1996 · 51 citations

, , +12

Bripiodionen, a New Inhibitor of Human Cytomegalovirus Protease from <i>Streptomyces</i> sp. WC76599

Yue‐Zhong Shu, Qingmei Ye, Janet M. Kolb et al. · Journal of Natural Products · 1997 · 20 citations

, , +9

The effect of cerulenin on the production of esperamicin A1 byActinomadura verrucosospora

Kin S. Lam, DONALD R. GUSTAVSON, Judith A. Veitch et al. · Journal of Industrial Microbiology & Biotechnology · 1993 · 17 citations · Full text

, , +1

Biosynthesis of Elsamicin A, a Novel Antitumor Antibiotic

Kin S. Lam, Judith A. Veitch, Salvatore Forenza et al. · Journal of Natural Products · 1989 · 12 citations

, , +6

1–5 of 5